Earnings Feed
Start Free
Liberty Latin America Ltd.·4

Jul 17, 8:11 PM ET

Nair Balan 4

4 · Liberty Latin America Ltd. · Filed Jul 17, 2026

Research Summary

AI-generated summary of this filing

Updated

Liberty Latin America (LILA) CEO Nair Balan Receives 131,916 RSU Awards

What Happened

  • Nair Balan, President and CEO of Liberty Latin America Ltd. (tickers LILA / LILAB / LILAK), recorded three "other acquisition or disposition (J)" transactions on 2026-06-17 that together added 131,916 derivative awards (23,622 + 46,359 + 61,935) at $0.00. These are restricted share unit (RSU) rights that represent the right to receive Series A Preference Shares at settlement (see footnote F1). No cash was paid in these transactions — the awards reflect an adjustment/conversion tied to a special dividend declared May 21, 2026.

Key Details

  • Transaction date: 2026-06-17; Filing date: 2026-07-17 (filed about one month after transaction — late relative to the usual 2-business-day Form 4 rule).
  • Amounts: 23,622; 46,359; and 61,935 RSU-based derivative awards; total = 131,916 units; price reported = $0.00 (no cash).
  • These RSUs represent rights to newly issued 9.0% Fixed Rate Cumulative Perpetual Series A Preferred Shares (initial liquidation price $25 per preferred share) created as part of a special dividend (0.10 Series A Preference share per common share) declared May 21, 2026 and payable June 16, 2026 (record date June 1).
  • Adjustment details: Original common-stock-linked RSUs were adjusted under the incentive plan’s anti-dilution provisions so holders received RSUs tied to Preferred Shares (footnote F2). The RSUs vest in full on March 15, 2027 (footnote F3). Ownership after the transactions is not specified in the provided excerpt.
  • These entries are derivative/award adjustments (code J) rather than open-market purchases or sales.

Context

  • This filing documents an administrative adjustment/conversion of equity awards following a special dividend, not an open-market trade. For retail investors, these transactions are not direct bullish or bearish trades in the market — they reflect changes in the form of compensation/awards tied to the dividend. The late filing may be a reporting-timeliness issue but does not by itself indicate insider intent.

Insider Transaction Report

Form 4
Period: 2026-06-17
Liberty Latin America Ltd.LILA
Nair Balan
DirectorPresident and CEO
Transactions
  • Other

    Restricted Share Units P

    [F1][F2][F3]
    2026-06-17+23,622→ 23,622 total
    → Series A Preference Shares (23,622 underlying)
  • Other

    Restricted Share Units P

    [F1][F2][F4]
    2026-06-17+46,359→ 46,359 total
    → Series A Preference Shares (46,359 underlying)
  • Other

    Restricted Share Units P

    [F1][F2][F5]
    2026-06-17+61,935→ 61,935 total
    → Series A Preference Shares (61,935 underlying)
Holdings

  • Share Appreciation Rights A

    [F6][F7]
    Exercise: $15.10Exp: 2028-01-02→ Class A Common Shares (286,000 underlying)
    286,000

  • Share Appreciation Rights C

    [F6][F8]
    Exercise: $14.56Exp: 2028-01-02→ Class C Common Shares (588,000 underlying)
    588,000

  • Share Appreciation Rights A

    [F6][F9]
    Exercise: $13.03Exp: 2028-05-01→ Class A Common Shares (165,508 underlying)
    165,508

  • Share Appreciation Rights C

    [F6][F10]
    Exercise: $12.41Exp: 2028-05-01→ Class C Common Shares (340,275 underlying)
    340,275

  • Share Appreciation Rights A

    [F6][F11]
    Exercise: $13.93Exp: 2029-05-01→ Class A Common Shares (175,642 underlying)
    175,642

  • Share Appreciation Rights C

    [F6][F12]
    Exercise: $13.63Exp: 2029-05-01→ Class C Common Shares (361,111 underlying)
    361,111

  • Share Appreciation Rights A

    [F6][F13]
    Exercise: $7.29Exp: 2030-03-16→ Class A Common Shares (315,649 underlying)
    315,649

  • Share Appreciation Rights C

    [F6][F14]
    Exercise: $7.13Exp: 2030-03-16→ Class C Common Shares (648,957 underlying)
    648,957

  • Share Appreciation Rights A

    [F6][F15]
    Exercise: $9.80Exp: 2031-03-16→ Class A Common Shares (1,430,000 underlying)
    1,430,000

  • Share Appreciation Rights C

    [F6][F16]
    Exercise: $9.60Exp: 2031-03-16→ Class C Common Shares (2,940,000 underlying)
    2,940,000

  • Share Appreciation Rights A

    [F6][F17]
    Exercise: $9.80Exp: 2031-03-16→ Class A Common Shares (280,079 underlying)
    280,079

  • Share Appreciation Rights C

    [F6][F18]
    Exercise: $9.60Exp: 2031-03-16→ Class C Common Shares (575,828 underlying)
    575,828

  • Share Appreciation Rights A

    [F6][F19]
    Exercise: $6.78Exp: 2032-03-11→ Class A Common Shares (430,025 underlying)
    430,025

  • Share Appreciation Rights C

    [F6][F20]
    Exercise: $6.56Exp: 2032-03-11→ Class C Common Shares (884,107 underlying)
    884,107

  • Share Appreciation Rights A

    [F6][F21]
    Exercise: $6.78Exp: 2032-03-11→ Class A Common Shares (33,078 underlying)
    33,078

  • Share Appreciation Rights C

    [F6][F22]
    Exercise: $6.56Exp: 2032-03-11→ Class C Common Shares (68,008 underlying)
    68,008

  • Share Appreciation Rights A

    [F6][F23]
    Exercise: $5.47Exp: 2033-03-20→ Class A Common Shares (498,317 underlying)
    498,317

  • Share Appreciation Rights C

    [F6][F24]
    Exercise: $5.30Exp: 2033-03-20→ Class A Common Shares (1,024,513 underlying)
    1,024,513

  • Share Appreciation Rights A

    [F25][F26]
    Exercise: $4.31Exp: 2034-03-12→ Class A Common Shares (639,344 underlying)
    639,344

  • Share Appreciation Rights C

    [F25][F27]
    Exercise: $4.24Exp: 2034-03-12→ Class C Common Shares (1,314,456 underlying)
    1,314,456

  • Share Appreciation Rights A

    [F28][F29]
    Exercise: $4.68Exp: 2035-03-14→ Class A Common Shares (610,605 underlying)
    610,605

  • Share Appreciation Rights C

    [F28][F30]
    Exercise: $4.54Exp: 2035-03-14→ Class C Common Shares (1,255,371 underlying)
    1,255,371

  • Share Appreciation Rights A

    [F31][F32]
    Exercise: $5.31Exp: 2036-03-13→ Class A Common Shares (558,048 underlying)
    558,048

  • Share Appreciation Rights C

    [F31][F33]
    Exercise: $5.29Exp: 2036-03-13→ Class C Common Shares (1,147,317 underlying)
    1,147,317
Footnotes (33)
  • [F1]Each Restricted Share Unit P ("RSU") represents a right to receive one share of the Issuer's Series A Preference Shares at settlement.
  • [F10]This SAR was previously reported as a SAR relating to 231,480 shares of the Issuer's common stock at a base price of $18.24 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F11]This SAR was previously reported as a SAR relating to 122,827 shares of the Issuer's common stock at a base price of $19.91 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F12]This SAR was previously reported as a SAR relating to 245,654 shares of the Issuer's common stock at a base price of $20.03 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F13]This SAR was previously reported as a SAR relating to 220,734 shares of the Issuer's common stock at a base price of $10.42 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F14]This SAR was previously reported as a SAR relating to 441,468 shares of the Issuer's common stock at a base price of $10.48 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F15]This SAR was previously reported as a SAR relating to 1,000,000 shares of the Issuer's common stock at a base price of $14.00 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F16]This SAR was previously reported as a SAR relating to 2,000,000 shares of the Issuer's common stock at a base price of $14.10 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F17]This SAR was previously reported as a SAR relating to 195,860 shares of the Issuer's common stock at a base price of $14.00 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F18]This SAR was previously reported as a SAR relating to 391,720 shares of the Issuer's common stock at a base price of $14.10 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F19]This SAR was previously reported as a SAR relating to 300,717 shares of the Issuer's common stock at a base price of $9.69 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F2]In connection with the Dividend (as defined in Remarks), all RSUs with respect to the Issuer's common stock ("Original RSUs") were adjusted pursuant to the anti-dilution provisions of the incentive plans under which the RSU awards held by the reporting person were granted. Each holder of an Original RSU was entitled to receive an RSU with respect to a number of Preferred Shares equal to 0.10 multiplied by the number of shares of common stock underlying the Original RSU, subject to the same terms and conditions as the Original RSU. These adjustments were approved by the Issuer's board of directors pursuant to Rule 16b-3.
  • [F20]This SAR was previously reported as a SAR relating to 601,434 shares of the Issuer's common stock at a base price of $9.63 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F21]This SAR was previously reported as a SAR relating to 23,132 shares of the Issuer's common stock at a base price of $9.69 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F22]This SAR was previously reported as a SAR relating to 46,264 shares of the Issuer's common stock at a base price of $9.63 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F23]This SAR was previously reported as a SAR relating to 348,474 shares of the Issuer's common stock at a base price of $7.81 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F24]This SAR was previously reported as a SAR relating to 696,948 shares of the Issuer's common stock at a base price of $7.78 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F25]The SARs vest in full on March 15 2027.
  • [F26]This SAR was previously reported as a SAR relating to 447,094 shares of the Issuer's common stock at a base price of $6.16 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F27]This SAR was previously reported as a SAR relating to 894,188 shares of the Issuer's common stock at a base price of $6.22 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F28]The Share Appreciation Rights vest in two equal annual installments on March 15 of 2027 and 2028.
  • [F29]This SAR was previously reported as a SAR relating to 426,997 shares of the Issuer's common stock at a base price of $6.69 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F3]The Restricted Share Units vest in full on March 15, 2027.
  • [F30]This SAR was previously reported as a SAR relating to 853,994 shares of the Issuer's common stock at a base price of $6.66 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F31]The Share Appreciation Rights vest in three equal annual installments on March 15 of 2027, 2028 and 2029
  • [F32]This SAR was previously reported as a SAR relating to 390,244 shares of the Issuer's common stock at a base price of $7.58 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F33]This SAR was previously reported as a SAR relating to 780,488 shares of the Issuer's common stock at a base price of $7.77 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F4]The RSUs vest in two equal annual installments on March 15 of 2027 and 2028.
  • [F5]The RSUs vest in three equal annual installments on March 15 of 2027, 2028 and 2029.
  • [F6]The derivative security is fully vested.
  • [F7]This SAR was previously reported as a SAR relating to 200,000 shares of the Issuer's common stock at a base price of $21.58 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F8]This SAR was previously reported as a SAR relating to 400,000 shares of the Issuer's common stock at a base price of $21.39 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
  • [F9]This share appreciation right award ("SAR") was previously reported as a SAR relating to 115,740 shares of the Issuer's common stock at a base price of $18.63 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
Signature
/s/ John M. Winter, Attorney-in-Fact|2026-07-17

Documents

1 file
  • 4
    wk-form4_1784333490.xmlPrimary

    FORM 4